Euclidean Capital as of March 31, 2025
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ishares Tr Msci India Etf (INDA) | 46.9 | $125M | 2.4M | 51.48 | |
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 45.4 | $121M | 2.0M | 60.66 | |
| Foghorn Therapeutics (FHTX) | 2.2 | $5.7M | 1.6M | 3.65 | |
| Oric Pharmaceuticals (ORIC) | 2.1 | $5.5M | 989k | 5.58 | |
| Pmv Pharmaceuticals (PMVP) | 1.1 | $2.9M | 2.6M | 1.09 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.9 | $2.3M | 4.1k | 559.39 | |
| Alector (ALEC) | 0.6 | $1.6M | 1.3M | 1.23 | |
| Surrozen Com New (SRZN) | 0.4 | $1.0M | 88k | 11.66 | |
| Rapt Therapeutics | 0.3 | $803k | 658k | 1.22 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $579k | 1.0M | 0.57 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $5.1k | 171k | 0.03 |
